Evidence map›Paper›PMID 33411212›Full record

ArticleJournal of physiology and biochemistry2021

MicroRNA-520c-3p suppresses vascular endothelium dysfunction by targeting RELA and regulating the AKT and NF-κB signaling pathways.

Yan Jiao, Dandan Zhao, Fuhua Gao, Xiaoyan Hu, Xinxin Hu, Mei Li, Ying Cui, Xiaoqing Wei, Ce Xie, Ying Zhao and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of physiology and biochemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. MicroRNAs Regulate Function in Atherosclerosis and Clinical Implications.Oxidative medicine and cellular longevity · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Yan Jiao *Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Dalian Medical University, Dalian, China.
Dandan Zhao *Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Dalian Medical University, Dalian, China.
Fuhua GaoDepartment of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Dalian Medical University, Dalian, China.
Xiaoyan HuDepartment of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Dalian Medical University, Dalian, China.
Xinxin HuDepartment of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Dalian Medical University, Dalian, China.
Mei LiDepartment of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Dalian Medical University, Dalian, China.
Ying CuiLiaoning Provincial Core Lab of Medical Molecular Biology, Dalian Medical University, Dalian, China.
Xiaoqing WeiLiaoning Provincial Core Lab of Medical Molecular Biology, Dalian Medical University, Dalian, China.
Ce XieLiaoning Provincial Core Lab of Medical Molecular Biology, Dalian Medical University, Dalian, China.
Ying ZhaoLiaoning Provincial Core Lab of Medical Molecular Biology, Dalian Medical University, Dalian, China. zhaoying20001105@126.com.
Ying GaoDepartment of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Dalian Medical University, Dalian, China. gaoying200018@126.com.ORCID http://orcid.org/0000-0001-9521-2978
Dalian Medical University · CN

Funding

Department of Education of Liaoning Province 2017502656National Natural Science Foundation of China 31070719National Natural Science Foundation of China 31370800National Natural Science Foundation of China 81402916National Natural Science Foundation of China (CN) 30470394
6 · The paper itself

Abstract

Endothelial injury, which can cause endothelial inflammation and dysfunction, is an important mechanism for the development of atherosclerotic plaque. This study aims to investigate the functional role of miR-520c-3p in vascular endothelium during inflammatory diseases such as atherosclerosis. Quantitative real-time PCR was used to detect miR-520c-3p expression in in human umbilical vein endothelial cells (HUVECs) after treatment with platelet-derived growth factor (PDGF). Furthermore, the effects of miR-520c-3p overexpression and silencing on cell proliferation, adhesion, and apoptosis were assessed. Bioinformatics analysis and Biotin-labeled miRNA pull-down assay were used to confirm the targets of miR-520-3p. Then, the effects of miR-520c-3p on AKT and NF-κB signaling pathways were detected by western blot. Herein, we observed that the expression level of miR-520c-3p was downregulated in HUVECs under PDGF stimulation. Overexpression of miR-520c-3p not only decreased cell adhesion but also promoted proliferation and inhibited apoptosis to protect the viability of endothelial cells. It was confirmed that RELA is the target of miR-520c-3p. MiR-520c-3p inhibited the protein phosphorylation of AKT and RELA, and si-RELA reversed the promotion of AKT and RELA protein phosphorylation by anti-miR-520c-3p. In summary, our study suggested that miRNA-520c-3p targeting RELA through AKT and NF-κB signaling pathways regulated the proliferation, apoptosis, and adhesion of vascular endothelial cells. We conclude that miR-520c-3p may play an important role in the suppression of endothelial injury, which could serve as a biomarker and therapeutic target for atherosclerosis.

Indexed as

ApoptosisAtherosclerosisCell AdhesionCell ProliferationHumansHuman Umbilical Vein Endothelial CellsMicroRNAsNF-kappa BProto-Oncogene Proteins c-aktSignal TransductionTHP-1 CellsTranscription Factor RelAMicroRNAsMIRN520 microRNA, humanNF-kappa BProto-Oncogene Proteins c-aktRELA protein, humanTranscription Factor RelACell adhesion and apoptosisEndothelial injurymiR-520c-3pRELA

Identifiers

PMID33411212
OpenAlexW3119941147

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.